Job Description
We are a rapidly growing company headquartered in New York that focuses on creating Artificial Intelligence to help better pharma and healthcare businesses. Our apps use computer vision to confirm the patient's identity, verify that they're taking the right medication, and that the patient is taking it.
We are seeking a Strategic Sales Account Manager that will be responsible for executing the end to end sales process. If you enjoy building strong client relationships, have extensive knowledge of clinical trials, and having amazing critical thinking skills then this is the job for YOU!
Responsibilities:
- Develops and enhances client relationships with a specific focus on supporting client relationships with assigned accounts
- Challenges and reframes the way clients look at clinical trials in the context our of our company
- Serves as a trusted advisor for our strategic accounts
- Possess deep knowledge of client business and can discuss issues from multiple angles
- Comfortable with frequent travel
Requirements
- 3+ years of successful sales experience in Pharma and/or Biotech (MSL background in sales preferred)
- Experience in clinical trials
- Experience selling SAAS, medical/mobile devices
- Ability to influence senior level executives in Pharma and/or Biotech industry
Company Description
Not only is Collabera committed to meeting and exceeding our customer’s needs, but we also are committed to our employees’ satisfaction as well. We believe our employees are the cornerstone of our success and we make every effort to ensure their satisfaction throughout their tenure with Collabera. We offer an enriching experience that promotes career growth and lifelong learning for our employees. As a result of these efforts, we have been recognized by Staffing Industry Analysts (SIA) as one of the “Best Staffing Firms to Work For” since 2012 – eight consecutive years in a row. Collabera has 60 offices with a presence in 11 countries and provides staff augmentation, managed services and direct placement services to Fortune 500 corporations across the globe.